Revenue: The sum of all revenue fields included for a company's operating activities.
Silence Therapeutics PLC Sponsored ADR (SLN) had Revenue of $43.26M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$43.26M |
$-45.31M |
|
$11.81M |
|
$31.45M |
|
$106.58M |
|
$-63.32M |
|
$18.86M |
|
$-44.46M |
|
$-44.46M |
|
$-45.31M |
|
$-45.31M |
|
$-45.31M |
|
$-45.31M |
|
$-63.32M |
|
$-62.73M |
|
46.25M |
|
46.25M |
|
$-0.98 |
|
$-0.98 |
|
| Balance Sheet Financials | |
$187.37M |
|
$1.82M |
|
$15.27M |
|
$202.63M |
|
$16.82M |
|
-- |
|
$51.79M |
|
$68.61M |
|
$134.02M |
|
$124.32M |
|
$134.02M |
|
47.23M |
|
| Cash Flow Statement Financials | |
$-67.64M |
|
$-21.97M |
|
$142.09M |
|
$68.79M |
|
$121.33M |
|
$52.54M |
|
$16.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
72.70% |
|
-146.38% |
|
-146.38% |
|
-145.00% |
|
-102.79% |
|
-104.74% |
|
$-67.85M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
1.71 |
|
214.05 |
|
-33.81% |
|
-36.45% |
|
-22.36% |
|
-33.81% |
|
$2.84 |
|
$-1.47 |
|
$-1.46 |
|